Literature DB >> 2194787

Progesterone as a bone-trophic hormone.

J C Prior1.   

Abstract

Experimental, epidemiological, and clinical data indicate that progesterone is active in bone metabolism. Progesterone appears to act directly on bone by engaging an osteoblast receptor or indirectly through competition for a glucocorticoid osteoblast receptor. Progesterone seems to promote bone formation and/or increase bone turnover. It is possible, through estrogen-stimulated increased progesterone binding to the osteoblast receptor, that progesterone plays a role in the coupling of bone resorption with bone formation. A model of the interdependent actions of progesterone and estrogen on appropriately-"ready" cells in each bone multicellular unit can be tied into the integrated secretions of these hormones within the ovulatory cycle. Figure 5 is an illustration of this concept. It shows the phases of the bone remodeling cycle in parallel with temporal changes in gonadal steroids across a stylized ovulatory cycle. Increasing estrogen production before ovulation may reverse the resorption occurring in a "sensitive" bone multicellular unit while gonadal steroid levels are low at the time of menstrual flow. The bone remodeling unit would then be ready to begin a phase of formation as progesterone levels peaked in the midluteal phase. From this perspective, the normal ovulatory cycle looks like a natural bone-activating, coherence cycle. Critical analysis of the reviewed data indicate that progesterone meets the necessary criteria to play a causal role in mineral metabolism. This review provides the preliminary basis for further molecular, genetic, experimental, and clinical investigation of the role(s) of progesterone in bone remodeling. Much further data are needed about the interrelationships between gonadal steroids and the "life cycle" of bone. Feldman et al., however, may have been prophetic when he commented; "If this anti-glucocorticoid effect of progesterone also holds true in bone, then postmenopausal osteoporosis may be, in part, a progesterone deficiency disease."

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2194787     DOI: 10.1210/edrv-11-2-386

Source DB:  PubMed          Journal:  Endocr Rev        ISSN: 0163-769X            Impact factor:   19.871


  31 in total

Review 1.  Regulation of Bone Metabolism by Sex Steroids.

Authors:  Sundeep Khosla; David G Monroe
Journal:  Cold Spring Harb Perspect Med       Date:  2018-01-02       Impact factor: 6.915

2.  Differential modulation of glucocorticoid and progesterone receptor transactivation.

Authors:  Daniele Szapary; Liang-Nian Song; Yuangzheng He; S Stoney Simons
Journal:  Mol Cell Endocrinol       Date:  2007-12-08       Impact factor: 4.102

Review 3.  Toward a cure for osteoporosis: reversal of excessive bone fragility.

Authors:  C H Turner
Journal:  Osteoporos Int       Date:  1991-10       Impact factor: 4.507

4.  Does the degree of endocrine dyscrasia post-reproduction dictate post-reproductive lifespan? Lessons from semelparous and iteroparous species.

Authors:  Craig S Atwood; Kentaro Hayashi; Sivan Vadakkadath Meethal; Tina Gonzales; Richard L Bowen
Journal:  Geroscience       Date:  2017-03-07       Impact factor: 7.713

5.  Identification of location and kinetically defined mechanism of cofactors and reporter genes in the cascade of steroid-regulated transactivation.

Authors:  John A Blackford; Chunhua Guo; Rong Zhu; Edward J Dougherty; Carson C Chow; S Stoney Simons
Journal:  J Biol Chem       Date:  2012-10-10       Impact factor: 5.157

Review 6.  That oestrogen replacement for osteoporosis prevention should no longer be a bone of contention.

Authors:  T G Palferman
Journal:  Ann Rheum Dis       Date:  1993-01       Impact factor: 19.103

7.  Depot medroxyprogesterone acetate and osteoporosis. Smoking may explain findings.

Authors:  J B Sharma; M R Newman; R J Smith
Journal:  BMJ       Date:  1994-03-12

8.  The pregnancy hormones human chorionic gonadotropin and progesterone induce human embryonic stem cell proliferation and differentiation into neuroectodermal rosettes.

Authors:  Miguel J Gallego; Prashob Porayette; Maria M Kaltcheva; Richard L Bowen; Sivan Vadakkadath Meethal; Craig S Atwood
Journal:  Stem Cell Res Ther       Date:  2010-09-13       Impact factor: 6.832

9.  Progesterone and bone: actions promoting bone health in women.

Authors:  Vanadin Seifert-Klauss; Jerilynn C Prior
Journal:  J Osteoporos       Date:  2010-10-31

10.  Bone growth and turnover in progesterone receptor knockout mice.

Authors:  David J Rickard; Urszula T Iwaniec; Glenda Evans; Theresa E Hefferan; Jamie C Hunter; Katrina M Waters; John P Lydon; Bert W O'Malley; Sundeep Khosla; Thomas C Spelsberg; Russell T Turner
Journal:  Endocrinology       Date:  2008-02-14       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.